New report 2026 AI SDR market benchmark: six platforms, eight workflow stages See the results →

Raportul

Știri verificate despre finanțări, sedii centrale și leadership de la cele mai inovatoare companii din lume

77 rapoarte și mai multe

Actualizat zilnic cu ultimele informații de piață
Fundraising
Advanced NanoTherapies

Advanced NanoTherapies Raises Over $31M Series B for Dual-Drug Vascular Balloons

Advanced NanoTherapies announced the closing of an oversubscribed Series B financing of more than $31 million, co-led by S3 Ventures and an undisclosed strategic investor.

SalesTools Research
Jun 2, 2026
2 min read•$31M+
Fundraising
Rakuten Medical

Rakuten Medical Raises $100M Series F | Photoimmunotherapy Cancer Treatment

Cancer treatment company Rakuten Medical secures $100 million Series F led by TaiAx for Phase 3 trials.

SalesTools Research
Jan 8, 2026
0 min read•$100M
Fundraising
Corsera Health

Corsera Health Raises $80M Series A | Once-Yearly Cardiovascular RNAi

Biotech startup Corsera Health secures $80 million Series A for once-yearly RNAi cardiovascular treatments.

SalesTools Research
Jan 10, 2026
0 min read•$80M
MedTech
NeuroLink Brain

NeuroLink Brain Raises $580M Series D to Transform Healthcare

NeuroLink Brain secures $580M in Series D funding at $8.2B valuation to complete fda approval process, scale manufacturing for clinical deployment, and expand treatment applications.

Editorial Team
Sep 9, 2025
0 min read•$580M
Fundraising
AirNexis Therapeutics

AirNexis Therapeutics Raises $200M Series A | Novel COPD Treatment

Biotech AirNexis Therapeutics emerges from stealth with $200 million Series A for dual PDE3/4 inhibitor COPD therapy.

SalesTools Research
Jan 11, 2026
0 min read•$200M
HealthTech
Evommune

Evommune raises $50M Series B at $300M valuation

Evommune raises $50M in Series B at $300M valuation. Oral immunology treatments...

Editorial Team
Aug 1, 2025
0 min read•$50M
HealthTech
NRG Therapeutics

NRG Therapeutics raises $67M Series B

NRG Therapeutics raises $67M in Series B. Developing treatments for ALS and neurodegenerative diseases...

Editorial Team
Sep 8, 2025
0 min read•$67M
HealthTech
Kardigan

Kardigan raises $300M Series A

Kardigan raises $300M in Series A. Healthcare company developing innovative treatments for cardiometabolic diseases...

Editorial Team
Sep 24, 2025
0 min read•$300M
Biotech
Seaport Therapeutics

Seaport Therapeutics raises $225M Series C at $1.2B valuation

Seaport Therapeutics raises $225M in Series C at $1.2B valuation. Neuropsychiatric disease treatments...

Editorial Team
Sep 12, 2024
0 min read•$225M
Pagina 1

Afișare 9 rapoarte • Pagina 1 • Categorie: all

Rămâneți înaintea pieței

Primiți perspective săptămânale în inbox. Fără spam, doar inteligență.